Obesity, Epidemiology and Risk
Sponsored by: Novo Nordisk
This resource will assess your knowledge of the epidemiology and comorbidities of obesity. You'll receive 1 hour of CPD on successful completion of this resource.
Resource Overview
The prevalence of obesity has increased sharply amongst developing and developed nations such that it now represents a global pandemic. Due to the associated co-morbidities of Diabetes, Cardiovascular Disease, Arthritis and Cancer, this represents not just a threat to wellbeing but also poses a financial threat to fragile healthcare systems.
Furthermore, the world has woken up to the fact that obesity has been recognised as a risk factor for a worse prognosis with COVID-19 infection. This module explores the pathophysiology of weight gain, control of appetite and also the related co-morbidities.
Aims and Objectives
On completion of this resource, you should have:
- Improved understanding of the regulation of appetite and potential therapeutic targets
- Critical understanding of the comorbidities that associate with weight gain